3 Asian Stocks Estimated To Be Trading At Discounts Ranging From 22.3% To 40.8%
In recent weeks, Asian markets have experienced a mix of volatility and resilience amid global economic shifts, with geopolitical tensions and fluctuating energy prices influencing investor sentiment. As investors navigate these turbulent times, identifying undervalued stocks can be a strategic approach to potentially capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| TOKAI (TSE:9729) | ¥2575.00 | ¥5037.09 | 48.9% |
| Riken Technos (TSE:4220) | ¥2446.00 | ¥4768.79 | 48.7% |
| Nissui (TSE:1332) | ¥1080.00 | ¥2141.38 | 49.6% |
| Monde Nissin (PSE:MONDE) | ₱6.35 | ₱12.68 | 49.9% |
| Marco Polo Marine (SGX:5LY) | SGD0.119 | SGD0.23 | 48.9% |
| Kumagai GumiLtd (TSE:1861) | ¥1203.00 | ¥2380.29 | 49.5% |
| Innocean Worldwide (KOSE:A214320) | ₩18010.00 | ₩35939.95 | 49.9% |
| Inner Mongolia ERDOS ResourcesLtd (SHSE:600295) | CN¥14.34 | CN¥28.17 | 49.1% |
| Astellas Pharma (TSE:4503) | ¥2262.50 | ¥4494.42 | 49.7% |
| ARE Holdings (TSE:5857) | ¥3445.00 | ¥6698.35 | 48.6% |
We'll examine a selection from our screener results.
WingArc1st (TSE:4432)
Overview: WingArc1st Inc. is a Japanese company that offers software and services, with a market capitalization of ¥121.48 billion.
Operations: The company generates revenue from its Data Empowerment Business, amounting to ¥31.44 billion.
Estimated Discount To Fair Value: 22.3%
WingArc1st is trading at ¥3,495, significantly below its estimated future cash flow value of ¥4,498.28. Despite modest expected annual earnings growth of 12.5%, this rate surpasses the Japanese market's average of 9.6%. Recent earnings showed improvement with net income rising to ¥1,559.21 million from a year ago. The company announced a share repurchase program to enhance shareholder returns and capital efficiency but has not executed any buybacks yet as of August 2026.
- Insights from our recent growth report point to a promising forecast for WingArc1st's business outlook.
- Unlock comprehensive insights into our analysis of WingArc1st stock in this financial health report.
Ono Pharmaceutical (TSE:4528)
Overview: Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceuticals and diagnostic reagents globally, with a market cap of ¥1.06 trillion.
Operations: The company generates revenue primarily from its Pharmaceutical Business, amounting to ¥504.41 billion.
Estimated Discount To Fair Value: 33.9%
Ono Pharmaceutical, priced at ¥2,265.5, trades 33.9% below its estimated future cash flow value of ¥3,427.32. Despite a reliable dividend yield of 3.53%, the company's earnings and revenue are forecast to decline over the next three years by an average of 3.1% and 1.2% annually, respectively. Recent strategic collaborations with Biohaven and Aitia aim to enhance its drug portfolio in Asia and globally through innovative AI-driven discoveries in neurology and autoimmune diseases.
- Upon reviewing our latest growth report, Ono Pharmaceutical's projected financial performance appears quite optimistic.
- Click to explore a detailed breakdown of our findings in Ono Pharmaceutical's balance sheet health report.
Fuji Seal International (TSE:7864)
Overview: Fuji Seal International, Inc. specializes in the planning, development, manufacturing, and sales of packaging systems with a market cap of ¥189.45 billion.
Operations: The company generates revenue through its core activities of planning, proposal, development, manufacturing, and sales within the packaging systems sector.
Estimated Discount To Fair Value: 40.8%
Fuji Seal International, at ¥3,550, trades significantly below its estimated future cash flow value of ¥5,997.77. Despite a 65.2% earnings growth last year and good relative value compared to peers, the company's earnings are projected to decline by 4.5% annually over the next three years. Recent guidance indicates net sales of ¥228.6 billion for fiscal year ending March 2027 with dividends adjusted slightly downward overall for the year end compared to previous forecasts.
- According our earnings growth report, there's an indication that Fuji Seal International might be ready to expand.
- Delve into the full analysis health report here for a deeper understanding of Fuji Seal International.
Key Takeaways
- Click through to start exploring the rest of the 175 Undervalued Asian Stocks Based On Cash Flows now.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com